A comprehensive view of Lonza Group Ltd. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Chemicals Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

'Extracellular Vesicle Conjugates And Uses Thereof' in Patent Application Approval Process (USPTO 20240108747)
Published: April 18, 2024 by Cancer Vaccine Daily
'Extracellular Vesicle Compositions' in Patent Application Approval Process (USPTO 20240099973)
Published: April 12, 2024 by Vaccine Daily
Lonza announces collaboration with NeuroSense Therapeutics, providing access to Lonza's extracellular vesicles expertise, supporting NeuroSense's research into neurodegenerative disease therapies
Published: April 11, 2024 by ENP Newswire
Lonza Sales Submits Patent Application for Extracellular Vesicle Conjugates and Uses Thereof
Published: April 06, 2024 by Pharmaceutical Patent News
Lonza Group Ltd Spearheads Alzheimer's Drug Breakthrough and Innovates in Cell Therapy Inspection
Published: April 04, 2024 by Industry Intelligence Inc.

Ask us about our Chemicals Industry market view

Trending Chart

Interactive chart with headline count